These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 19788931)

  • 21. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Con: Impedance-pH testing does not commonly alter management of GERD.
    Richter JE
    Am J Gastroenterol; 2009 Nov; 104(11):2667-9. PubMed ID: 19888231
    [No Abstract]   [Full Text] [Related]  

  • 23. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease.
    Dellon ES; Shaheen NJ
    Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864
    [No Abstract]   [Full Text] [Related]  

  • 25. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review article: modern technology in the diagnosis of gastro-oesophageal reflux disease--Bilitec, intraluminal impedance and Bravo capsule pH monitoring.
    Hirano I
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():12-24. PubMed ID: 16483266
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addition of esophageal impedance monitoring to pH monitoring increases the yield of symptom association analysis in patients off PPI therapy.
    Bredenoord AJ; Weusten BL; Timmer R; Conchillo JM; Smout AJ
    Am J Gastroenterol; 2006 Mar; 101(3):453-9. PubMed ID: 16464226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [How to raise efficacy of gastroesophageal reflux disease treatment].
    Vakhrushev IaM; Potapova LO; Muravtseva OV
    Ter Arkh; 2009; 81(2):27-30. PubMed ID: 19334485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of symptomatic reflux episodes on Acid suppressive therapy.
    Tutuian R; Vela MF; Hill EG; Mainie I; Agrawal A; Castell DO
    Am J Gastroenterol; 2008 May; 103(5):1090-6. PubMed ID: 18445095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impedance-pH testing.
    Villa N; Vela MF
    Gastroenterol Clin North Am; 2013 Mar; 42(1):17-26. PubMed ID: 23452628
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Twenty-four-hour esophageal impedance-pH monitoring in healthy preterm neonates: rate and characteristics of acid, weakly acidic, and weakly alkaline gastroesophageal reflux.
    López-Alonso M; Moya MJ; Cabo JA; Ribas J; del Carmen Macías M; Silny J; Sifrim D
    Pediatrics; 2006 Aug; 118(2):e299-308. PubMed ID: 16831894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
    Beaumont H; Boeckxstaens GE
    Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Esophageal acid exposure on proton pump inhibitors in unselected asymptomatic gastroesophageal reflux disease patients.
    Grigolon A; Cantù P; Savojardo D; Conte D; Penagini R
    J Clin Gastroenterol; 2008 Oct; 42(9):969-73. PubMed ID: 18719508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An analysis of persistent symptoms in acid-suppressed patients undergoing impedance-pH monitoring.
    Sharma N; Agrawal A; Freeman J; Vela MF; Castell D
    Clin Gastroenterol Hepatol; 2008 May; 6(5):521-4. PubMed ID: 18356117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between gastric pH and gastro-oesophageal reflux contents: ambulatory pH-impedance monitoring results.
    Roman S; Serraj I; Damon H; Mion F
    Neurogastroenterol Motil; 2007 Jul; 19(7):562-8. PubMed ID: 17593137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence, characteristics, and treatment outcomes of reflux hypersensitivity detected on pH-impedance monitoring.
    Patel A; Sayuk GS; Gyawali CP
    Neurogastroenterol Motil; 2016 Sep; 28(9):1382-90. PubMed ID: 27061427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnosis and therapy of weakly-acid/non-acidic gastroesophageal reflux disease].
    Meining A; Bajbouj M; Stein HJ; Schmid RM
    Dtsch Med Wochenschr; 2005 Oct; 130(40):2266-9. PubMed ID: 16208602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Impedance-pH analysis in gastroesophageal reflux monitoring].
    Szaflarska-Popławska A; Popławski C; Mierzwa G
    Pol Merkur Lekarski; 2007 Oct; 23(136):302-6. PubMed ID: 18293856
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged ambulatory pH monitoring in patients with persistent gastroesophageal reflux disease symptoms: testing while on therapy identifies the need for more aggressive anti-reflux therapy.
    Katzka DA; Paoletti V; Leite L; Castell DO
    Am J Gastroenterol; 1996 Oct; 91(10):2110-3. PubMed ID: 8855731
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined pH-metry/impedance monitoring increases the diagnostic yield in patients with atypical gastroesophageal reflux symptoms.
    Bajbouj M; Becker V; Neuber M; Schmid RM; Meining A
    Digestion; 2007; 76(3-4):223-8. PubMed ID: 18174685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.